Used as a key intermediate in the synthesis of biologically active compounds, particularly in pharmaceutical development. Its structure supports the construction of peptidomimetics and enzyme inhibitors, where the fluorine atom enhances metabolic stability and influences binding affinity. Commonly employed in the preparation of drug candidates targeting central nervous system disorders and metabolic diseases due to its favorable conformational properties and compatibility with solid-phase synthesis techniques.